578717-93-8Relevant articles and documents
ISOINDOLINE INHIBITORS OF ROR-GAMMA
-
Paragraph 0273, (2016/06/01)
Provided are novel compounds of Formula (I): pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, which are useful in the treatment of diseases and disorders mediated by RORγ. Also provided are pharmaceutical compositions comprising the novel compounds of Formula (I) and methods for their use in treating one or more inflammatory, metabolic, autoimmune and other diseases or disorders.